- Press Release -

The usage of microscopy devices has registered an uptick in the past few years. Microscopes have allowed in-depth academic and exploratory research in various branches of science. Amongst the wide range of sciences, the life sciences division has found increased usage of microscopy devices, particularly in cell biology. Also, the need for more penetrative media to identify cells has boosted technological developments in microscopic devices. On the back of these trends, the global microscopy devices market is poised to expand 1.6x, registering a CAGR of 8.5% throughout the forecast period (2020-2025).

Nowadays, major life science companies are increasingly seeking the services of contract research organizations (CROs) to reduce their overall expenditure and concentrate on their core businesses. This has enabled several microscopy service providers to invest in research and development of microscopes. The ongoing coronavirus pandemic is anticipated to leverage market prospects. With the number of infections climbing at an exponential rate, hospitals and other healthcare settings have experienced an uptick in the number of diagnostic tests to determine the presence of the virus. On the back of this, the usage of microscopes to detect potential pathogens has increased. Leading players are therefore concentrating on streamlining their production processes to cater to this increased demand.

Key Takeaways of Global Microscopy Devices Market Study:

• Optical microscopes are projected to account for a major chunk of the market, capturing more than three-fifths of the market share. Rising demand for different types of optical microscopes such as fluorescence and inverted microscopes and low cost of stereo and phase contrast microscopes shall drive the segment’s growth.
• By application, Cell and Molecular Biology and Biomedical engineering are anticipated to make exhaustive utilization of microscopy devices. This is due to increased adoption of microscopes in microbiology, cell culture, healthcare monitoring and launch of new therapeutic products. Projected CAGR for both segments is pegged at 8.3%.
• Clinical Pathology and Diagnostics shall find equally important microscopy applications, for understanding pathological changes in conditions such as Alzheimer’s and Parkinson’s diseases and chronic diseases. Anticipated CAGR for this segment is a staggering 8.2%.
• By end-users, diagnostic laboratories are anticipated to find maximum usage of microscopy devices. The need to accurately identify potentially life-threatening diseases such as tuberculosis and immunological ailments such as HIV-AIDS and diabetes in order to suggest appropriate corrective course of action is anticipated to drive the segment’s growth.
• Asia-Pacific is projected to emerge as the leader of the global microscopy devices market, capturing more than half of the total market share. An emerging pharmaceutical industry, liberalization and deregulation of key markets and rising adoption of electron and scanning probe microscopes shall drive the Asia-Pacific regional growth.
• However, North America is projected to soar in popularity due to increased patent filing approvals, increased government funding for life sciences projects, greater flexibility in regulations and high transparency. Besides, adoption of optical microscopes is poised to increase during the forecast period. The region is set to expand 1.6x, capturing nearly one-fourth of the global microscopy devices market.

“The global microscopy devices market is poised to experience a healthy growth trajectory. Rising incentives for research in life sciences in the form of government funding, relaxation of regulations and growing healthcare infrastructure are anticipated to leverage the prospects of microscopy devices,” concludes a Fact.MR analyst.

Technological Developments to Boost Key Players’ Market Prospects:

The global microscopy devices market consists of the following key market players: Olympus Corporation, JOEL Ltd., Nikon Corporation, Carl Zeiss Microscopy GmBh, FEI Company, Leica Microsystems, Hitachi High-Technologies Corporation, Bruker Corporation and CAMECA SAS. Most of these market players rely on technological advancements to increase market presence.

For instance, in November 2016, Nikon Corporation launched its new inverted microscope, titled the ECLIPSE Ti2, which provides improved stability and usability in research applications of life sciences. Its current microscope product portfolio include the SMZ25/SMZ18, ShuttlePix and A1MP/A1RMP series. The company also manufactures stereo microscopes, upright microscopes, super resolution microscopes and digital microscopes.

Another market leader, Olympus Corporation, manufactures biological microscope products. Its microscope categories include upright microscopes, stereo microscopes, inverted microscopes, laser scanning microscopes and super resolution microscopes. Specific microscope brands include the SpinSR10, the BX53, the FV3000 Series and the IXPlore series.

Looking for more information?

The research study on the global microscopy market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global microscopy market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of product type (optical microscopy, scanning probe microscopy, electron microscopy and microscopy accessories) application (cell and molecular biology, pharmacology and toxicology, clinical pathology and diagnostics, surgery, biomedical engineering, neuroscience and others) and end-users (hospitals, ambulatory surgical centers, diagnostic laboratories, physician offices and academic and research institutes) across five major regions.

Fact. MR’s Domain Knowledge in Healthcare

Fact .MR’s healthcare and research professionals guide organizations at each step of their business strategy by helping you understand how contemporary influencers impact transformation in the healthcare sector. Our expertise in recognizing the challenges and trends affecting the global healthcare industry provides valuable insight and support, helping identify critical issues and construct relevant solutions.